Swaroop Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Uttar Pradesh, Uttar Pradesh, India, established in 1998.
1998 Uttar Pradesh, Uttar Pradesh, India Active
Last Updated:
Access Report
About Swaroop Pharmaceuticals Private Limited

Swaroop Pharmaceuticals Private Limited, a active private limited company, was established on 08 May 1998 in Uttar Pradesh, Uttar Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231UP1998PTC023440. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹4.00 Cr.

It upholds a compliant status. Employing 18 professional, Its leadership includes Vineet Kela (Director), Puneet Kela (Director), Atul Agrawal (Director). It holds ₹12.00 Cr open charges and ₹15.81 Cr settled loans. Its latest AGM occurred on 28 September 2024, with the balance sheet filed on 31 March 2024. It is based at Ram Kutir Kela Nagar Aligarh, Uttar Pradesh, Uttar Pradesh, 202001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231UP1998PTC023440

  • Registration Number

    023440

  • Incorporation Date

    08 May 1998

  • Authorized Capital

    ₹5.00 Cr

  • Paid-Up Capital

    ₹4.00 Cr

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 4.00 Cr
  • Company Age 27 Year, 9 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 12.00 Cr
  • Satisfied Charges ₹ 15.81 Cr
  • Revenue Growth **** 55.84%
  • Profit Growth **** 274.71%
  • Ebitda **** -64.15%
  • Net Worth 16.54%
  • Total Assets **** 41.56%
Company report

Swaroop Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Swaroop Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Swaroop Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Vineet Kela Director 08 May 1998 Current
Puneet Kela Director 08 May 1998 Current
Atul Agrawal Director 31 Mar 2008 Current
Sanjay Maheshwari Director 08 May 1998 Current
Vijay Maheshwari Director 08 May 1998 Current
Jaiprakash Agarwal Director 31 Mar 2008 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Swaroop Pharmaceuticals.

Swaroop Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 55.84% increase. The company also saw a substantial improvement in profitability, with a 274.71% increase in profit. The company's net worth Soared by an impressive increase of 16.54%.

Swaroop Pharmaceuticals revenue growth over time
Swaroop Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 55.84%
*******
*******
*******
*******
Revenue from Operations
*******
 55.84%
*******
*******
*******
*******
Total Assets
*******
 41.56%
*******
*******
*******
*******
Profit or Loss
*******
 274.71%
*******
*******
*******
*******
Net Worth
*******
 16.54%
*******
*******
*******
*******
EBITDA
*******
 -64.15%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Swaroop Pharmaceuticals?

In 2023, Swaroop Pharmaceuticals had a promoter holding of 71.52% and a public holding of 28.48%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹120,000,000.00

Satisfied Charges

₹158,119,000.00

Charges Breakdown by Lending Institutions
  • Others : 12.00 Cr
Latest Charge Details
Date Lender Amount Status
18 Dec 2024 Others ₹12.00 Cr Open
30 Jul 2020 Others ₹6.50 M Satisfied
30 Jul 2020 Others ₹1.30 Cr Satisfied
16 Mar 2012 Bank Of Baroda ₹9.90 Cr Satisfied
17 Sep 2008 Bank Of India ₹3.96 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Swaroop Pharmaceuticals?

Swaroop Pharmaceuticals has a workforce of 18 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Swaroop Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Swaroop Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Swaroop Pharmaceuticals
Recent Activity within the Organization
  • Charges

    A charge registered on 30 Jul 2020 via Charge ID 100367699 with Others was fully satisfied on 15 Jan 2025. was recorded as a recent event.

  • Charges

    The activity A charge registered on 30 Jul 2020 via Charge ID 100367710 with Others was fully satisfied on 15 Jan 2025. was completed.

  • Charges

    The activity A charge registered on 16 Mar 2012 via Charge ID 10344602 with Bank Of Baroda was fully satisfied on 15 Jan 2025. was completed.

  • Charges

    A charge with Others amounted to Rs. 12.00 Cr with Charge ID 101029410 was registered on 18 Dec 2024. was recorded as a recent event.

  • Annual General Meeting

    The activity Swaroop Pharmaceuticals Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Swaroop Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Swaroop Pharmaceuticals Private Limited?

The CIN of Swaroop Pharmaceuticals Private Limited is U24231UP1998PTC023440.

Where is Swaroop Pharmaceuticals Private Limited headquartered?

Swaroop Pharmaceuticals Private Limited is headquartered at Ram Kutir Kela Nagar Aligarh, Uttar Pradesh, Uttar Pradesh, 202001.

When was Swaroop Pharmaceuticals Private Limited incorporated?

Swaroop Pharmaceuticals Private Limited was incorporated on 08 May 1998.

Who are the current directors of Swaroop Pharmaceuticals Private Limited?

The current directors of Swaroop Pharmaceuticals Private Limited are

What is the primary industry of Swaroop Pharmaceuticals Private Limited?

The primary industry of Swaroop Pharmaceuticals Private Limited is Manufacturing.

Is Swaroop Pharmaceuticals Private Limited a listed company?

Swaroop Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Swaroop Pharmaceuticals Private Limited?

The authorized capital of Swaroop Pharmaceuticals Private Limited is ₹5.00 Cr, and the paid-up capital is ₹4.00 Cr.

What is the compliance status of Swaroop Pharmaceuticals Private Limited?

The compliance status of Swaroop Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available